Cargando…

Impact of palliative therapies in metastatic esophageal cancer patients not receiving chemotherapy

BACKGROUND: Palliative therapy has been associated with improved overall survival (OS) in several tumor types. Not all patients with metastatic esophageal cancer receive palliative chemotherapy, and the roles of other palliative therapies in these patients are limited. AIM: To investigate the impact...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Sungjin, DiPeri, Timothy P, Guan, Michelle, Placencio-Hickok, Veronica R, Kim, Haesoo, Liu, Jar-Yee, Hendifar, Andrew, Klempner, Samuel J, Nipp, Ryan, Gangi, Alexandra, Burch, Miguel, Waters, Kevin, Cho, May, Chao, Joseph, Atkins, Katelyn, Kamrava, Mitchell, Tuli, Richard, Gong, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2020
Materias:	Retrospective Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520571/ https://www.ncbi.nlm.nih.gov/pubmed/33024512 http://dx.doi.org/10.4240/wjgs.v12.i9.377

Ejemplares similares

Chemotherapy predictors and a time-dependent chemotherapy effect in metastatic esophageal cancer
por: Midthun, Lauren, et al.
Publicado: (2022)

A Comparison of Clinicopathologic Outcomes Across Neoadjuvant and Adjuvant Treatment Modalities in Resectable Gastric Cancer
por: Anderson, Eric, et al.
Publicado: (2021)

Treatment strategies and clinical outcomes of locally advanced pancreatic cancer patients treated at high-volume facilities and academic centers
por: David, John M., et al.
Publicado: (2018)

Therapeutic Advances and Challenges in the Management of HER2-Positive Gastroesophageal Cancers
por: Chuang, Jeremy, et al.
Publicado: (2022)

Palliative Radiation Therapy for Bone Metastases in Neuroendocrine Neoplasms
por: Guan, Michelle, et al.
Publicado: (2019)

Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study
por: Gong, Jun, et al.
Publicado: (2022)

The gut microbiome and response to immune checkpoint inhibitors: preclinical and clinical strategies
por: Gong, Jun, et al.
Publicado: (2019)

Fecal elastase, an assay for exocrine pancreatic insufficiency, has clinical utility in patients with pancreatic ductal adenocarcinoma
por: Gong, Jun, et al.
Publicado: (2020)

Total neoadjuvant therapy for locally advanced gastric cancer: too much of a good thing?
por: DiPeri, Timothy P., et al.
Publicado: (2023)

Feasibility and efficacy of enteral tube feeding on weight stability, lean body mass, and patient‐reported outcomes in pancreatic cancer cachexia
por: Gresham, Gillian, et al.
Publicado: (2021)

A phase 1 study of veliparib, a PARP-1/2 inhibitor, with gemcitabine and radiotherapy in locally advanced pancreatic cancer
por: Tuli, R., et al.
Publicado: (2019)

Multiplatform profiling of pancreatic neuroendocrine tumors: Correlative analyses of clinicopathologic factors and identification of co-occurring pathogenic alterations
por: Gong, Jun, et al.
Publicado: (2019)

Combined morphologic and metabolic pipeline for Positron emission tomography/computed tomography based radiotherapy response evaluation in locally advanced pancreatic adenocarcinoma
por: Lao, Yi, et al.
Publicado: (2019)

Pancreatic cancer ‘mismatch’ in Lynch syndrome
por: Hendifar, Andrew E, et al.
Publicado: (2019)

Underutilization of palliative care services in the liver transplant population
por: Kathpalia, Priya, et al.
Publicado: (2016)

Jejunostomy in the palliative treatment of gastric cancer: A clinical prognostic score
por: Ramos, Marcus Fernando Kodama Pertille, et al.
Publicado: (2021)

Risk profiles and outcomes of patients receiving antibacterial cardiovascular implantable electronic device envelopes: A retrospective analysis
por: Woodard, David A, et al.
Publicado: (2022)

POLE-Mutant Colon Cancer Treated with PD-1 Blockade Showing Clearance of Circulating Tumor DNA and Prolonged Disease-Free Interval
por: Bikhchandani, Mihir, et al.
Publicado: (2023)

Clinical Applications of Minimal Residual Disease Assessments by Tumor-Informed and Tumor-Uninformed Circulating Tumor DNA in Colorectal Cancer
por: Gong, Jun, et al.
Publicado: (2021)

Self-expanding metal stents for the palliation of malignant gastric outlet obstruction in patients with peritoneal carcinomatosis
por: Rademacher, Christoph, et al.
Publicado: (2016)

Safety and efficacy of transjugular intrahepatic portosystemic shunt combined with palliative treatment in patients with hepatocellular carcinoma
por: Luo, Shi-Hua, et al.
Publicado: (2019)

Plasma Metabolomics Predicts Chemotherapy Response in Advanced Pancreatic Cancer
por: Muranaka, Hayato, et al.
Publicado: (2023)

African Americans are less likely to receive curative treatment for hepatocellular carcinoma
por: Sobotka, Lindsay A, et al.
Publicado: (2018)

Trans-arterial chemoperfusion for the treatment of liver metastases of breast cancer and colorectal cancer: Clinical results in palliative care patients
por: Gruber-Rouh, Tatjana, et al.
Publicado: (2017)

Women receive more inpatient resections and ablations for hepatocellular carcinoma than men
por: Sobotka, Lindsay, et al.
Publicado: (2017)

High-dose-rate fractionated brachytherapy monotherapy for localized prostate cancer: a systematic review and meta-analysis
por: Anderson, Eric M., et al.
Publicado: (2021)

Feasibility of gastric endoscopic submucosal dissection with continuous low-dose aspirin for patients receiving dual antiplatelet therapy
por: Harada, Hideaki, et al.
Publicado: (2019)

Validation of the six-and-twelve criteria among patients with hepatocellular carcinoma and performance score 1 receiving transarterial chemoembolization
por: Wang, Zhe-Xuan, et al.
Publicado: (2020)

Risk factors, incidence, and morbidity associated with antibiotic-associated diarrhea in intensive care unit patients receiving antibiotic monotherapy
por: Zhou, Hong, et al.
Publicado: (2020)

Genetic determinants and potential therapeutic targets for pancreatic adenocarcinoma
por: Reznik, Robert, et al.
Publicado: (2014)

Hepatocellular carcinoma progression in hepatitis B virus-related cirrhosis patients receiving nucleoside (acid) analogs therapy: A retrospective cross-sectional study
por: Yang, Dan-Hong, et al.
Publicado: (2021)

Colorectal adenocarcinoma patients with M1a diseases gain more clinical benefits from palliative primary tumor resection than those with M1b diseases: A propensity score matching analysis
por: Li, Cheng-Lin, et al.
Publicado: (2020)

Neutrophil-to-lymphocyte ratio and carbohydrate antigen 19-9 as prognostic markers for advanced pancreatic cancer patients receiving first-line chemotherapy
por: Shin, Kabsoo, et al.
Publicado: (2021)

Effect of pelvic fixation on ambulation in children with neuromuscular scoliosis
por: Drake, Luke, et al.
Publicado: (2022)

Evaluation of Mobile Health Applications to Track Patient-Reported Outcomes for Oncology Patients: A Systematic Review
por: Lu, Diana J., et al.
Publicado: (2020)

Paid Parental Leave Policies Among U.S. News & World Report 2020-2021 Best Hospitals and Best Hospitals for Cancer
por: Lu, Diana J., et al.
Publicado: (2021)

Impact of laparoscopic liver resection on bleeding complications in patients receiving antithrombotics
por: Fujikawa, Takahisa, et al.
Publicado: (2017)

Association of Parental Status and Gender With Burden of Multidisciplinary Tumor Boards Among Oncology Physicians
por: Chau, Brittney L., et al.
Publicado: (2023)

Meta-analyses of treatment standards for pancreatic cancer
por: GONG, JUN, et al.
Publicado: (2016)

Combination systemic therapies with immune checkpoint inhibitors in pancreatic cancer: overcoming resistance to single-agent checkpoint blockade
por: Gong, Jun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8k2rh0qj9eumt1r4eavjm8r24l